Solvias is a world leader in contract research, development and manufacturing. Our name is derived from the Latin terms ‘solutio’ and ‘via’, embedding our promise to explore new ways to find solutions that surpass our customers’ requirements. For over 20 years, Solvias has been an essential link in the value chain for our customers across the pharmaceutical, biotech, medical device and cosmetic industries. Our comprehensive portfolio of integrated services and solutions backed by professional project management spans all stages of drug development including custom synthesis of drug product.

Beyond our expertise in small molecules, we have built a solid reputation for the characterization and analysis of monoclonal antibodies, therapeutic proteins and biosimilars. These cutting-edge capabilities enable Solvias to address the complex challenges of advanced therapeutic medicinal products (ATMPs): vaccines, cell and gene therapeutics, as well as nucleic acid-based products.

Solvias has its headquarters and main laboratories in Kaiseraugst, Switzerland, and complementary facilities in Basel, France and the USA. As a science-driven service organization with a company-wide quality culture, our highly qualified employees take pride in delivering unrivalled expertise, service and value according to our core values of respect, responsibility and reliability. Our laboratories operate to the highest quality standards in accordance with ISO, GMP, GLP and FDA regulations.